|
|
|
Xtalks, Online
2024-11-15
Discover an insightful webinar focusing on the latest US Food and Drug Administration (FDA) guidelines on diversity in clinical trials.
In this webinar, the expert speakers will explore how these new standards can be met and discuss actionable strategies for integrating diversity requirements into clinical trials by optimizing study design and increasing participant engagement.
They will also discuss real-world examples of how organizations have successfully achieved diversity goals and improved clinical trial outcomes. The expert speakers will also provide a detailed understanding of the FDA’s new diversity guidance and focus on the latest requirements for diversity action plans and how these regulations impact study design and clinical trial outcomes.
The attendees will get to learn how study inclusivity can be enhanced by helping to identify diverse patient populations, streamlining participant recruitment and ensuring compliance with the FDA’s new diversity standards.
Register for this webinar today to explore the latest FDA guidelines on clinical trial diversity and how compliance with these standards can be achieved.
Keywords: Clinical Research, Patient Recruitment, Regulatory, Diversity, Participant Diversity, Patient Diversity, Clinical Trial Diversity, Diversity and Inclusion, Diversity and Inclusion in Clinical Trials, Sites
|
|
|
|
|
|
|
Organized by:
|
|
Xtalks |
|
Invited Speakers:
|
|
Joshua Hartman, Director, Clinical Study Feasibility & Analytics, TriNetX
|
|
|
|
|
|
Deadline for Abstracts:
|
|
2024-11-15
|
|
|
|
|
|
|
Registration:
|
|
Free Registration
|
|
E-mail:
|
|
tristan@xtalks.com
|
|
|
|
|
|
|
|
|
|
|
|